(Q68234592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Gastric inhibitory polypeptide (GIP) response in diabetes using a highly specific antiserum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Gastric Inhibitory Polypeptide (GIP) Response in Diabetes Using a Highly Specific Antiserum (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

20 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

20 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

20 October 2022

author name string

M. J. Alam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643802

20 October 2022

J. I. Kerr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643802

20 October 2022

K. Cormican

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643802

20 October 2022

K. D. Buchanan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643802

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1643802

20 October 2022

publication date

1 July 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1992.tb01835.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1992.tb01835.x/fullpdf

20 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

20 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

542-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

22 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

The incretin concept today

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

New developments in the incretin concept

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Gastric inhibitory polypeptide: a gut hormone with anabolic functions

20 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Identification and Actions of Gastric Inhibitory Polypeptide

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

The effect of endogenous gastric inhibitory polypeptide on glucose-induced insulin secretion in mild diabetes

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Gastric Inhibitory Polypeptide Response to Hyper- and Hypoglycemia in Insulin-Dependent Diabetics*

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Fasting and postprandial plasma GIP values in man measured with seven different antisera.

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Immunoreactive gastric inhibitory polypeptide

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Radioimmunoassay of gastric inhibitory polypeptide

20 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

A radioimmunoassay of gastric inhibitory polypeptide in human plasma.

20 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat.

20 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01835.X

20 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643802%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference